0      0

2020 ISPE Biopharmaceutical Manufacturing Virtual Conference


Regulatory and Industry Insights & Lessons Learned


Jun 24, 2020 12:00am ‐ Sep 11, 2020 6:08am

Description

Regulatory and Industry Insights & Lessons Learned

Closing Plenary Session & Fireside Chat - Regulatory and Industry Insights & Lessons Learned Wrapping up the conference it is important to hear from regulatory leaders to help frame the strategy for the era ahead.  Lessons learned from organizations around the world will give individuals the most current insights for those difficult discussion back at your home base. 

  • Facilitating Development of Advanced Therapies
    Raj K. Puri, MD, Director, Division of Cellular & Gene Therapies
    CBER, FDA  
  • Industry and Regulatory Fireside Chat
    Raj K. Puri, MD, PhD, Director, Division of Cellular & Gene Therapies
    CBER, FDA
    Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment
    CDER, FDA
    John Balchunas, Workforce Director National Institute for
    Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
    Lawrence Hill, CEO & VP Global Clinical Development
    Gan & Lee USA
    Maria Hoffman, Executive Director, Supply Chain Management
    Merck
  • Closing Remarks & Adjourn
    Joseph Famulare, Conference Chair, VP Global Compliance & External Collaboration
    Genentech

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content